
New research reveals concerning links between gabapentin use in chronic pain patients and increased dementia risk. Essential reading for pharmacists and healthcare providers.

Discover how pharmacists can close critical care gaps in diabetic neuropathy affecting 50% of diabetes patients through proactive screening, medication management, and patient education.

Pharmacists are increasingly positioned to enhance community health by offering point-of-care test-and-treat (POCT-and-treat) services for common infectious conditions.

FDA issues new liver injury warning for Veozah (fezolinetant), a menopause hot flash treatment. Learn about required monitoring, symptoms to watch, and safety updates.


FDA approves Neffy, the first epinephrine nasal spray for anaphylaxis treatment, offering a needle-free alternative to injections with comparable efficacy for emergency care.